IP74-04: Updated Analysis of Cost-Effectiveness Among Bladder-Sparing Treatments for BCG-Unresponsive CIS: Incorporating Recently Approved and Established Therapies

IP74-04: Updated Analysis of Cost-Effectiveness Among Bladder-Sparing Treatments for BCG-Unresponsive CIS: Incorporating Recently Approved and Established Therapies

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)

146A

Abstract

Speakers

Amanda Myers

Assistant ProfessorMD Anderson Cancer Center

Sessions

IP74: Health Services Research: Value of Care, Cost and Outcome Measures

Monday, May 18, 2026 7:00 AM to 9:00 AM

Meera Chappidi · University of California - San Francisco

Daniel Joyce · Vanderbilt University Medical Center

Jonathan Rubenstein · Chesapeake Urology Associates

Registered attendees

Scott Flanders

VP of Medical AffairsImmunityBio, Inc.

Log in

See all the content and easy-to-use features by logging in or registering!